FOXO3 and breast cancer: Similarly, FOXO3a can also activate miR-29b-2 and miR-338 to target vascular endothelial growth factor A (VEGF-A) and nucleotide-binding oligomerization domain 1 (NRP1), respectively, to inhibit the metastasis of breast cancer (Song et al., 2021).